The New Criterion

The flagging housing market and sagging consumer sentiment ahead of the federal and NSW elections have affected the performance of an unlikely ASX-listed exponent – the assisted reproduction outfit Virtus Health (VRT, $3.98). Judging from the market leader’s recent half…

The New Criterion

Virtus Health (VRT) $5.72 Monash IVF (MVF) $1.54 A pregnant pause, or the advent of a more permanent decline? The country’s biggest providers of assisted reproductive services – ARS to friends – are contending with a downturn in the baby-making…